Aligos Therapeutics


Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules.

Industries

Employees

51-200

Links


Org chart

Lawrence M. Blatt
Chairman & CEO
Collapse
Lucinda Y. Quan
EVP, Chief Business Officer & General Counsel
Julian A. Symons
EVP & Chief Scientific Officer
Dave Smith
Executive Vice President
Tse-I Lin
VP, Early Compound Development & Belgian Site Head
Dinah Misner
Vice President
Hardean E. Achneck
Chief Medical Officer
Kha le
Executive Director
Derrick de Leon
Vice President, Head Of IT And Cybersecurity
Sushmita M. Chanda
Chief Development Officer
Vivek Rajwanshi
Executive Director

Board & advisors

Jack B. Nielsen
Lead Independent Director